Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 223

1.

Borrelia miyamotoi: 43 Cases Diagnosed in France by Real-Time PCR in Patients With Persistent Polymorphic Signs and Symptoms.

Franck M, Ghozzi R, Pajaud J, Lawson-Hogban NE, Mas M, Lacout A, Perronne C.

Front Med (Lausanne). 2020 Feb 28;7:55. doi: 10.3389/fmed.2020.00055. eCollection 2020.

2.

All eyes on him: Argyll Robertson pupil in late syphilis.

Lemarie B, Matt M, Deconinck L, Perronne C, Dinh A, Davido B.

Int J Infect Dis. 2019 Jun;83:1-2. doi: 10.1016/j.ijid.2019.03.023. Epub 2019 Mar 20. No abstract available.

3.

Efficacy of cefoxitin for the treatment of urinary tract infection due to extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates.

Senard O, Bouchand F, Deconinck L, Matt M, Fellous L, Rottman M, Perronne C, Dinh A, Davido B.

Ther Adv Infect Dis. 2018 Nov 13;6:2049936118811053. doi: 10.1177/2049936118811053. eCollection 2019 Jan-Dec.

4.

Value of Patient Population Selection and Lyme Borreliosis Tests.

Lacout A, Marcy PY, Mas M, Perronne C, Franck M.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01517-18. doi: 10.1128/JCM.01517-18. Print 2019 Mar. No abstract available.

5.

Artemisia annua and Artemisia afra tea infusions vs. artesunate-amodiaquine (ASAQ) in treating Plasmodium falciparum malaria in a large scale, double blind, randomized clinical trial.

Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P.

Phytomedicine. 2019 Apr;57:49-56. doi: 10.1016/j.phymed.2018.12.002. Epub 2018 Dec 5.

6.

Fecal microbiota transplantation to eradicate vancomycin-resistant enterococci colonization in case of an outbreak.

Davido B, Batista R, Fessi H, Michelon H, Escaut L, Lawrence C, Denis M, Perronne C, Salomon J, Dinh A.

Med Mal Infect. 2019 May;49(3):214-218. doi: 10.1016/j.medmal.2018.11.002. Epub 2018 Nov 27.

PMID:
30502308
7.

Effect of Artemisia annua and Artemisia afra tea infusions on schistosomiasis in a large clinical trial.

Munyangi J, Cornet-Vernet L, Idumbo M, Lu C, Lutgen P, Perronne C, Ngombe N, Bianga J, Mupenda B, Lalukala P, Mergeai G, Mumba D, Towler M, Weathers P.

Phytomedicine. 2018 Dec 1;51:233-240. doi: 10.1016/j.phymed.2018.10.014. Epub 2018 Oct 10.

8.

Holistic or Dedicated Approach in Lyme Disease?

Lacout A, Marcy PY, Mas M, Perronne C.

Clin Infect Dis. 2019 May 17;68(11):1974-1975. doi: 10.1093/cid/ciy995. No abstract available.

PMID:
30462189
9.

The Persistent Lyme Disease: "True Chronic Lyme Disease" rather than "Post-treatment Lyme Disease Syndrome".

Lacout A, El Hajjam M, Marcy PY, Perronne C.

J Glob Infect Dis. 2018 Jul-Sep;10(3):170-171. doi: 10.4103/jgid.jgid_152_17. No abstract available.

10.

Blood cell disruption to significantly improve the Borrelia PCR detection sensitivity in borreliosis in humans.

Lacout A, Mone Y, Franck M, Marcy PY, Mas M, Veas F, Perronne C.

Med Hypotheses. 2018 Jul;116:1-3. doi: 10.1016/j.mehy.2018.04.012. Epub 2018 Apr 15.

PMID:
29857888
11.

Lyme disease & co-infections: role of adaptive immune system.

Lacout A, Thariat J, Hajjam ME, Marcy PY, Perronne C.

Future Microbiol. 2018 May;13:613-615. doi: 10.2217/fmb-2017-0252. Epub 2018 May 10. No abstract available.

PMID:
29745726
12.

Biofilms busters to improve the detection of Borrelia using PCR.

Lacout A, Dacher V, El Hajjam M, Marcy PY, Perronne C.

Med Hypotheses. 2018 Mar;112:4-6. doi: 10.1016/j.mehy.2018.01.005. Epub 2018 Jan 30.

PMID:
29447935
13.

Impact of a systematic alert for antimicrobial treatment durations exceeding seven days in a university hospital.

Bouchand F, Leplay C, Randuineau P, Fellous L, Maxime V, Matt M, Deconinck L, Sénard O, Lawrence C, Villart M, Salomon J, Perronne C, Davido B, Dinh A.

J Hosp Infect. 2018 Jun;99(2):159-161. doi: 10.1016/j.jhin.2018.02.001. Epub 2018 Feb 8. No abstract available.

PMID:
29427601
14.

Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.

de Truchis P, Assoumou L, Landman R, Mathez D, Le Dû D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C; ANRS 162-4D Study Group.

J Antimicrob Chemother. 2018 Mar 1;73(3):738-747. doi: 10.1093/jac/dkx434.

PMID:
29186458
15.

To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis.

Horowitz RI, Lacout A, Marcy PY, Perronne C.

Clin Microbiol Infect. 2018 Feb;24(2):210. doi: 10.1016/j.cmi.2017.09.015. Epub 2017 Oct 10. No abstract available.

16.

Reinforcement of an antimicrobial stewardship task force aims at a better use of antibiotics of last resort: the COLITIFOS study.

Davido B, Bouchand F, Dinh A, Perronne C, Villart M, Senard O, Salomon J.

Int J Antimicrob Agents. 2017 Aug;50(2):142-147. doi: 10.1016/j.ijantimicag.2017.03.030. Epub 2017 Jul 8.

PMID:
28694232
17.

Changes in eosinophil count during bacterial infection: revisiting an old marker to assess the efficacy of antimicrobial therapy.

Davido B, Makhloufi S, Matt M, Calin R, Senard O, Perronne C, Dinh A, Salomon J.

Int J Infect Dis. 2017 Aug;61:62-66. doi: 10.1016/j.ijid.2017.06.005. Epub 2017 Jun 13.

18.

Non-typhi Salmonella enterica urinary tract infections.

Mellon G, Delanoe C, Roux AL, Heym B, Dubourg O, Hardy P, Chevallier B, Perronne C, Rouveix E, Salomon J.

Med Mal Infect. 2017 Oct;47(6):389-393. doi: 10.1016/j.medmal.2017.04.010. Epub 2017 Jun 7.

PMID:
28600113
19.

Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis.

Olliaro PL, Merle C, Mthiyane T, Bah B, Kassa F, Amukoye E, N Diaye A, Perronne C, Lienhardt C, McIlleron H, Fielding K.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e01834-16. doi: 10.1128/AAC.01834-16. Print 2017 Jul.

20.

Dealing with Lyme Disease Treatment.

Lacout A, Marcy PY, El Hajjam M, Thariat J, Perronne C.

Am J Med. 2017 May;130(5):e221. doi: 10.1016/j.amjmed.2016.12.039. No abstract available.

PMID:
28431674
21.

Errancy on Lyme Diagnosis.

Perronne C, Lacout A, Marcy PY, El Hajjam M.

Am J Med. 2017 May;130(5):e219. doi: 10.1016/j.amjmed.2016.12.001. No abstract available.

PMID:
28431673
22.

Is faecal microbiota transplantation an option to eradicate highly drug-resistant enteric bacteria carriage?

Davido B, Batista R, Michelon H, Lepainteur M, Bouchand F, Lepeule R, Salomon J, Vittecoq D, Duran C, Escaut L, Sobhani I, Paul M, Lawrence C, Perronne C, Chast F, Dinh A.

J Hosp Infect. 2017 Apr;95(4):433-437. doi: 10.1016/j.jhin.2017.02.001. Epub 2017 Feb 6.

PMID:
28237504
23.

Implementation of a simple innovative system for postprescription antibiotic review based on computerized tools with shared access.

Bouchand F, Dinh A, Roux AL, Davido B, Michelon H, Lepainteur M, Legendre B, El Sayed F, Pierre I, Salomon J, Lawrence C, Perronne C, Villart M, Crémieux AC.

J Hosp Infect. 2017 Mar;95(3):312-317. doi: 10.1016/j.jhin.2016.11.011. Epub 2016 Nov 26.

PMID:
28108091
24.

Impact of Anti-Inflammatory Drugs on Pyogenic Vertebral Osteomyelitis: A Prospective Cohort Study.

Dinh A, Jean M, Bouchand F, Davido B, Descatha A, Duran C, Gras G, Perronne C, Mulleman D, Salomon J, Bernard L.

Int J Rheumatol. 2016;2016:9345467. Epub 2016 Oct 19.

25.

Prospective evaluation of antibiotic treatment for urological procedure in patients presenting with neurogenic bladder.

Weglinski L, Rouzaud C, Even A, Bouchand F, Davido B, Duran C, Salomon J, Perronne C, Denys P, Chartier-Kastler E, Dinh A.

Med Mal Infect. 2016 Sep;46(6):300-7. doi: 10.1016/j.medmal.2016.04.001. Epub 2016 May 27.

PMID:
27241225
26.

Evaluating antibiotic therapies prescribed to adult patients in the emergency department.

Grenet J, Davido B, Bouchand F, Sivadon-Tardy V, Beauchet A, Tritz T, Guyot C, Perronne C, Gaillard JL, Salomon J, Beaune S, Dinh A.

Med Mal Infect. 2016 Jun;46(4):207-14. doi: 10.1016/j.medmal.2016.04.006.

PMID:
27210280
27.

High rates of off-label use in antibiotic prescriptions in a context of dramatic resistance increase: a prospective study in a tertiary hospital.

Davido B, Bouchand F, Calin R, Makhloufi S, Lagrange A, Senard O, Perronne C, Villart M, Salomon J, Dinh A.

Int J Antimicrob Agents. 2016 Jun;47(6):490-4. doi: 10.1016/j.ijantimicag.2016.04.010. Epub 2016 May 11.

PMID:
27208900
28.

Diagnostic delay of pyogenic vertebral osteomyelitis and its associated factors.

Jean M, Irisson JO, Gras G, Bouchand F, Simo D, Duran C, Perronne C, Mulleman D, Bernard L, Dinh A.

Scand J Rheumatol. 2017 Jan;46(1):64-68. doi: 10.3109/03009742.2016.1158314. Epub 2016 Apr 21.

PMID:
27098514
29.

Serum protein electrophoresis: an interesting diagnosis tool to distinguish viral from bacterial community-acquired pneumonia.

Davido B, Badr C, Lagrange A, Makhloufi S, De Truchis P, Perronne C, Salomon J, Dinh A.

Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):899-902. doi: 10.1007/s10096-016-2613-0. Epub 2016 Mar 2.

PMID:
26936614
30.

Blood stream infections due to multidrug-resistant organisms among spinal cord-injured patients, epidemiology over 16 years and associated risks: a comparative study.

Dinh A, Saliba M, Saadeh D, Bouchand F, Descatha A, Roux AL, Davido B, Clair B, Denys P, Annane D, Perronne C, Bernard L.

Spinal Cord. 2016 Sep;54(9):720-5. doi: 10.1038/sc.2015.234. Epub 2016 Feb 16.

PMID:
26882486
31.

Implementing efficient and sustainable collaboration between National Immunization Technical Advisory Groups: Report on the 3rd International Technical Meeting, Paris, France, 8-9 December 2014.

Perronne C, Adjagba A, Duclos P, Floret D, Houweling H, Le Goaster C, Lévy-Brühl D, Meyer F, Senouci K, Wichmann O.

Vaccine. 2016 Mar 8;34(11):1325-30. doi: 10.1016/j.vaccine.2016.01.063. Epub 2016 Feb 6.

PMID:
26859237
32.

Lyme disease: time for a new approach?

Borgermans L, Perronne C, Balicer R, Polasek O, Obsomer V.

BMJ. 2015 Dec 3;351:h6520. doi: 10.1136/bmj.h6520. No abstract available.

PMID:
26634936
33.

Critical review of studies trying to evaluate the treatment of chronic Lyme disease.

Perronne C.

Presse Med. 2015 Jul-Aug;44(7-8):828-31. doi: 10.1016/j.lpm.2015.06.002. Epub 2015 Jul 20. No abstract available.

PMID:
26206701
34.

A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.

TEMPRANO ANRS 12136 Study Group, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni TD, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X.

N Engl J Med. 2015 Aug 27;373(9):808-22. doi: 10.1056/NEJMoa1507198. Epub 2015 Jul 20.

35.

Four days a week or less on appropriate anti-HIV drug combinations provided long-term optimal maintenance in 94 patients: the ICCARRE project.

Leibowitch J, Mathez D, de Truchis P, Ledu D, Melchior JC, Carcelain G, Izopet J, Perronne C, David JR.

FASEB J. 2015 Jun;29(6):2223-34. doi: 10.1096/fj.14-260315. Epub 2015 Apr 1.

PMID:
25833895
36.

Actinomyces graevenitzii pulmonary abscess mimicking tuberculosis in a healthy young man.

Gliga S, Devaux M, Gosset Woimant M, Mompoint D, Perronne C, Davido B.

Can Respir J. 2014 November/December;21(6):e75-e77.

37.

A four-month gatifloxacin-containing regimen for treating tuberculosis.

Merle CS, Fielding K, Sow OB, Gninafon M, Lo MB, Mthiyane T, Odhiambo J, Amukoye E, Bah B, Kassa F, N'Diaye A, Rustomjee R, de Jong BC, Horton J, Perronne C, Sismanidis C, Lapujade O, Olliaro PL, Lienhardt C; OFLOTUB/Gatifloxacin for Tuberculosis Project.

N Engl J Med. 2014 Oct 23;371(17):1588-98. doi: 10.1056/NEJMoa1315817. Erratum in: N Engl J Med. 2015 Apr 23;372(17):1677.

38.

Quantiferon-TB Gold: performance for ruling out active tuberculosis in HIV-infected adults with high CD4 count in Côte d'Ivoire, West Africa.

Danel C, Kabran M, Inwoley A, Badje A, Herrmann JL, Moh R, Lecarrou J, Gabillard D, Ntakpe JB, Deschamps N, Ouattara E, Perronne C, Eholie S, Anglaret X.

PLoS One. 2014 Oct 16;9(10):e107245. doi: 10.1371/journal.pone.0107245. eCollection 2014.

39.

Lyme and associated tick-borne diseases: global challenges in the context of a public health threat.

Perronne C.

Front Cell Infect Microbiol. 2014 Jun 3;4:74. doi: 10.3389/fcimb.2014.00074. eCollection 2014. Review. No abstract available.

40.

Chronic gonococcal arthritis with C5 deficiency presenting with brief flare-ups: case study and literature review.

Davido B, Dinh A, Lagrange A, Mellon G, de Truchis P, Perronne C, Cremieux AC.

Clin Rheumatol. 2014 Sep;33(9):1351-3. doi: 10.1007/s10067-014-2643-x. Epub 2014 Apr 29. Review.

PMID:
24777471
41.

Osler's node on the thigh, an uncommon location, but a valuable diagnostic aid.

Davido B, Davido N, Cremieux AC, de Truchis P, Perronne C.

Intern Emerg Med. 2014 Oct;9(7):815-6. doi: 10.1007/s11739-014-1063-x. Epub 2014 Feb 26. No abstract available.

PMID:
24570132
42.

Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response.

Krastinova E, Bani-Sadr F, Fromentin D, Goujard C, Hessamfar M, Yazdanpanah Y, Pol S, Cacoub P, Perronne C, Carrat F.

J Infect. 2014 May;68(5):462-6. doi: 10.1016/j.jinf.2013.12.007. Epub 2013 Dec 27.

PMID:
24378283
43.

α-Hemolysin, not Panton-Valentine leukocidin, impacts rabbit mortality from severe sepsis with methicillin-resistant Staphylococcus aureus osteomyelitis.

Crémieux AC, Saleh-Mghir A, Danel C, Couzon F, Dumitrescu O, Lilin T, Perronne C, Etienne J, Lina G, Vandenesch F.

J Infect Dis. 2014 Jun 1;209(11):1773-80. doi: 10.1093/infdis/jit840. Epub 2013 Dec 26.

PMID:
24376272
44.

Chondrocostal osteitis: an uncommon complication of gastrostomy tube placement.

Davido B, Rouzaud C, Hanachi M, De Truchis P, Dinh A, Perronne C.

Endoscopy. 2013;45 Suppl 2 UCTN:E259-60. doi: 10.1055/s-0033-1344562. Epub 2013 Sep 5. No abstract available.

PMID:
24008455
45.

Recurrent furunculosis: Efficacy of the CMC regimen--skin disinfection (chlorhexidine), local nasal antibiotic (mupirocin), and systemic antibiotic (clindamycin).

Davido B, Dinh A, Salomon J, Roux AL, Gosset-Woimant M, Pierre I, Perronne C, Bernard L.

Scand J Infect Dis. 2013 Nov;45(11):837-41. doi: 10.3109/00365548.2013.810815. Epub 2013 Jul 15.

PMID:
23848409
46.

Pasteurella infection after muraenidae bite in an HIV infected patient.

de Truchis P, Davido B, El Sayed F, Roux AL, Sow MS, Perronne C, Melchior JC.

Travel Med Infect Dis. 2013 Jul-Aug;11(4):250-1. doi: 10.1016/j.tmaid.2013.03.001. Epub 2013 Apr 19.

PMID:
23608461
47.

Comparison of six generic vancomycin products for treatment of methicillin-resistant Staphylococcus aureus experimental endocarditis in rabbits.

Tattevin P, Saleh-Mghir A, Davido B, Ghout I, Massias L, Garcia de la Maria C, Miró JM, Perronne C, Laurent F, Crémieux AC.

Antimicrob Agents Chemother. 2013 Mar;57(3):1157-62. doi: 10.1128/AAC.01669-12. Epub 2012 Dec 17.

48.

Personal protective equipment management and policies: European Network for Highly Infectious Diseases data from 48 isolation facilities in 16 European countries.

De Iaco G, Puro V, Fusco FM, Schilling S, Maltezou HC, Brouqui P, Gottschalk R, Bannister B, Brodt HR, Siikamaki H, Perronne C, Brantsæter AB, Fjellet AL, Ippolito G; European Network for Highly Infectious Diseases Working Group.

Infect Control Hosp Epidemiol. 2012 Oct;33(10):1008-16. doi: 10.1086/667729. Epub 2012 Aug 27.

PMID:
22961020
49.

Isolated subcutaneous tuberculous abscesses of the lumbar wall.

Jean M, Masse V, Carlier R, Perronne C, Crémieux AC.

J Travel Med. 2012 Sep-Oct;19(5):329-30. doi: 10.1111/j.1708-8305.2012.00634.x. Epub 2012 Jul 30. No abstract available.

50.

Hepatitis e virus infection in sheltered homeless persons, france.

Larrat S, Gaillard S, Baccard M, Piroth L, Cacoub P, Pol S, Perronne C, Carrat F, Morand P; French National Agency for Research on AIDS and viral hepatitis HC02 Ribavic Study Team.

Emerg Infect Dis. 2012 Jun;18(6):1031; author reply 1032. doi: 10.3201/eid1806.110632. No abstract available.

Supplemental Content

Loading ...
Support Center